Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Herceptin/Navelbine vs Taxotere/Carboplatin/Herceptin in Early HER2+ Breast Cancer
NCT00148668Phase 2Completed
- Start
- Dec 2003
- Primary completion
- Jan 2009
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, vinorelbine in breast cancer. Started Dec 2003; status: completed.
02
Drugs
trastuzumabvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00148668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148668.